Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.
The FDA recently confirmed that a new rule requiring healthcare providers to notify patients of their breast density status will be released in late 2022 or early 2023.
The new guidelines address issues with false negatives and positives from POC testing for fertility and reproductive health.
A roundup of the significant new diagnostic tests and products that received regulatory approval in the US and around the world.
In draft guidance, the FDA is proposing that medical device makers will need to consider how accessible their products are to underserved populations.
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.